NCT00922324View on ClinicalTrials.gov

Safety and Tolerability of STP206 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

November 30, 2010

Conditions
Healthy
Interventions
DRUG

STP206 or vehicle control

STP206 or vehicle administered as either a single dose or as a daily dose for 7 consecutive days

Trial Locations (1)

21201

SNBL Clinical Pharmacology Center, Inc., Baltimore

Sponsors
All Listed Sponsors
lead

Leadiant Biosciences, Inc.

INDUSTRY

NCT00922324 - Safety and Tolerability of STP206 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter